David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$686M |
| 2 |
Walt Disney
DIS
|
+$555M |
| 3 |
Palantir
PLTR
|
+$522M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$493M |
| 5 |
TSMC
TSM
|
+$464M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$981M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 4 |
Eli Lilly
LLY
|
+$555M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.18% |
| 2 | Healthcare | 9.91% |
| 3 | Consumer Discretionary | 9.25% |
| 4 | Financials | 6.45% |
| 5 | Industrials | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Caterpillar
CAT
$381B
| $219M | 0.19% |
663,058
+197,241
| +42% | +$70.3M |
|
102
PUT
ASML
ASML
$677B
| $219M | 0.19% |
329,800
+9,100
| +3% | +$6.62M |
|
103
Biogen
BIIB
$32B
| $217M | 0.19% |
1,585,572
-24,327
| -2% | -$3.48M |
|
104
CALL
Costco
COST
$420B
| $216M | 0.19% |
228,600
-203,400
| -47% | -$198M |
|
105
Best Buy
BBY
$18.1B
| $216M | 0.19% |
2,933,937
+956,546
| +48% | +$78.9M |
|
106
Canadian Natural Resources
CNQ
$106B
| $215M | 0.19% |
6,987,672
+4,236,003
| +154% | +$128M |
|
107
Sherwin-Williams
SHW
$84.1B
| $214M | 0.19% |
613,873
-589,266
| -49% | -$207M |
|
108
Philip Morris
PM
$293B
| $212M | 0.19% |
1,338,687
-402,176
| -23% | -$57M |
|
109
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.8B
| $212M | 0.19% |
4,274,400
+2,045,800
| +92% | +$102M |
|
110
Colgate-Palmolive
CL
$72.6B
| $211M | 0.19% |
2,252,162
+1,263,023
| +128% | +$113M |
|
111
Constellation Energy
CEG
$96.7B
| $211M | 0.19% |
1,045,733
-1,614,896
| -61% | -$433M |
|
112
Intercontinental Exchange
ICE
$90.5B
| $211M | 0.19% |
1,221,941
+144,145
| +13% | +$23.6M |
|
113
GE Aerospace
GE
$361B
| $211M | 0.19% |
1,052,358
-513,488
| -33% | -$101M |
|
114
DexCom
DXCM
$34.8B
| $210M | 0.19% |
3,081,769
-448,364
| -13% | -$36.6M |
|
115
Brinker International
EAT
$10.6B
| $208M | 0.19% |
1,396,926
-454,531
| -25% | -$69.9M |
|
116
Northrop Grumman
NOC
$78.3B
| $208M | 0.19% |
405,937
-242,331
| -37% | -$116M |
|
117
CALL
Goldman Sachs
GS
$303B
| $204M | 0.18% |
373,400
+18,700
| +5% | +$11.3M |
|
118
Edison International
EIX
$27.5B
| $202M | 0.18% |
3,434,713
+2,961,828
| +626% | +$170M |
|
119
Astera Labs
ALAB
$49.4B
| $201M | 0.18% |
3,376,245
+929,384
| +38% | +$86M |
|
120
PUT
Pfizer
PFE
$160B
| $201M | 0.18% |
7,944,900
-3,175,400
| -29% | -$83.1M |
|
121
Sprouts Farmers Market
SFM
$7.56B
| $199M | 0.18% |
1,301,950
+24,197
| +2% | +$3.61M |
|
122
JPMorgan Chase
JPM
$935B
| $199M | 0.18% |
810,125
+115,354
| +17% | +$29.4M |
|
|
MRSH
123
Marsh
MRSH
$91.6B
| $197M | 0.18% |
806,914
+461,843
| +134% | +$105M |
|
124
Medtronic
MDT
$119B
| $196M | 0.17% |
2,176,381
+103,175
| +5% | +$9.23M |
|
125
Johnson & Johnson
JNJ
$651B
| $195M | 0.17% |
1,173,990
+201,980
| +21% | +$31.6M |
|
Similar funds
David Shaw's Q1 2025 Portfolio in Review
As of Q1 2025, David Shaw held 4,902 positions worth $112B, down 18% from $136B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $21.6B in Q1 2025, closing 704 positions and reducing 1,734 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $951M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in KKR & Co 6.25% Series D Preferred Stock worth $88.2M.
- David Shaw's largest Q1 2025 buy was KKR & Co 6.25% Series D Preferred Stock: 1,800,000 shares worth $88.2M.
- David Shaw added most to GE Vernova in Q1 2025, an estimated $686M increase.
- David Shaw's biggest Q1 2025 reduction was Boeing, cutting an estimated $981M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $951M.
- David Shaw's ten largest holdings make up 11% of its $112B portfolio in Q1 2025.
- David Shaw opened 569 new positions and closed 704 in Q1 2025.
- David Shaw's portfolio value fell 18% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.